21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
10.89.Z - Production of other food products, not elsewhere classified
20.42.Z - Manufacture of cosmetics and toilet preparations
20.5 - Manufacture of other chemical products
21.10.Z - Manufacture of basic pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.76.Z - Wholesale trade
70.22.Z - Head office activities and management consultancy
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
82.92.Z - Packaging activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 15,8 | 95,5 | 46,6 | -51,2 |
EBITDA | 17,5 | 42,7 | 33,6 | -21,3 |
Short time liabilities | 42,1 | 34,6 | 12,7 | -63,4 |
Equity capital | 58,7 | 133,6 | 54,8 | -59 |
Operating profit (EBIT) | 16,7 | 41,3 | 32,6 | -21 |
Assets | 102,7 | 171,1 | 68,1 | -60,2 |
Net profit (loss) | 12,7 | 87,6 | 40,1 | -54,2 |
Cash | 6,8 | 76,7 | 26 | -66,1 |
Net income from sale | 86,2 | 151,5 | 113,8 | -24,9 |
Liabilities and provisions for liabilities | 44,1 | 37,5 | 13,3 | -64,5 |
Working assets | 75,5 | 140,4 | 46,1 | -67,2 |
Depreciation | 0,8 | 1,4 | 1 | -28,5 |
% | % | % | p.p. | |
Profitability of capital | 21,7 | 65,6 | 73,2 | 7,6 |
Equity capital to total assets | 57,1 | 78,1 | 80,4 | 2,3 |
Gross profit margin | 18,3 | 63,1 | 41 | -22,1 |
EBITDA Margin | 20,3 | 28,2 | 29,5 | 1,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 178 | 83 | 41 | -42 |
Current financial liquidity indicator | 1.7234139442443848 | 3.777068614959717 | 3.5255625247955322 | -0,3 |
Net dept to EBITDA | 0.9769316911697388 | -1.495441198348999 | -0.7749832272529602 | 0,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane